Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-07

Clinical Trial Update: Safety of PATANASE Nasal Spray in Patients With Perennial Allergic Rhinitis [Phase 4]

View source ↗

Summary

Phase 4 safety trial update for PATANASE nasal spray in perennial allergic rhinitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Patanase (olopatadine)

Snippet

Sponsor: Alcon Research | Conditions: Perennial Allergic Rhinitis | Phase 4 | Status: COMPLETED | Results posted: 2012-09-07